Newsletter #4 for September 22nd, 2021
Pfizer booster gets FDA emergency use authorization today, and inflammation dominates the theme of tonight's letter.
Key News Item
* While I was working late tonight, I learned that the FDA has extended its emergency use authorization to allow higher-risk people to receive the much-anticipated Pfizer booster shots already being given in other countries like Israel, Germany, France, and Britain. Moderna and J&J recipients will likely receive the same privilege soon.
Keep reading with a 7-day free trial